{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:11:53Z","timestamp":1768565513476,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3355,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1038\/sj.mt.6300213","type":"journal-article","created":{"date-parts":[[2007,5,29]],"date-time":"2007-05-29T14:20:15Z","timestamp":1180448415000},"page":"1487-1494","source":"Crossref","is-referenced-by-count":21,"title":["Characteristics of Lentiviral Vectors Harboring the Proximal Promoter of the vav Proto-oncogene: A Weak and Efficient Promoter for Gene Therapy"],"prefix":"10.1016","volume":"15","author":[{"given":"Elena","family":"Almarza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"R\u00edo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nestor W","family":"Meza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Aldea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xabier","family":"Agirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Guenechea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 C","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A","family":"Bueren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.mt.6300213_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1038\/sj.mt.6300213_bib2","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"10.1038\/sj.mt.6300213_bib3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"10.1038\/sj.mt.6300213_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm1393","article-title":"Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI 1, PRDM16 or SETBP1","volume":"12","author":"Ott","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/sj.mt.6300213_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.1068893","article-title":"Murine leukemia induced by retroviral gene marking","volume":"296","author":"Li","year":"2002","journal-title":"Science"},{"key":"10.1038\/sj.mt.6300213_bib6","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood-2004-11-4535","article-title":"Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis","volume":"11","author":"Modlich","year":"2005","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300213_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt1216","article-title":"Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration","volume":"24","author":"Montini","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1038\/sj.mt.6300213_bib8","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2005-10-4108","article-title":"Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque","volume":"107","author":"Seggewiss","year":"2006","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300213_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.mt.6300213_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1038\/sj.mt.6300213_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.gt.3302270","article-title":"Pois(s)on\u2014it's a question of dose","volume":"11","author":"Fehse","year":"2004","journal-title":"Gene Ther"},{"key":"10.1038\/sj.mt.6300213_bib12","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1182\/blood-2003-05-1424","article-title":"Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population","volume":"102","author":"Kustikova","year":"2003","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300213_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymthe.2003.10.013","article-title":"Chance or necessity? Insertional mutagenesis in gene therapy and its consequences","volume":"9","author":"Baum","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300213_bib14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.1105063","article-title":"Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene Marking","volume":"308","author":"Kustikova","year":"2005","journal-title":"Science"},{"key":"10.1038\/sj.mt.6300213_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hum.2006.17.253","article-title":"Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors","volume":"17","author":"Baum","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300213_bib16","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1128\/MCB.20.5.1461-1477.2000","article-title":"Regulatory and signaling properties of the Vav family","volume":"20","author":"Bustelo","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1038\/sj.mt.6300213_bib17","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/j.1460-2075.1989.tb08354.x","article-title":"vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells","volume":"8","author":"Katzav","year":"1989","journal-title":"EMBO J"},{"key":"10.1038\/sj.mt.6300213_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V91.2.419","article-title":"Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment","volume":"91","author":"Ogilvy","year":"1998","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300213_bib19","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/sj.mt.6300213_bib20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/jgm.951","article-title":"Functional analysis of gammaretroviral vector transduction by quantitative PCR","volume":"8","author":"Meza","year":"2006","journal-title":"J Gene Med"},{"key":"10.1038\/sj.mt.6300213_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jmg.2006.044719","article-title":"A comprehensive strategy for the subtyping of Fanconi Anemia patients: conclusions from the Spanish Fanconi Anemia research network","volume":"44","author":"Antonio Casado","year":"2007","journal-title":"J Med Genet"},{"key":"10.1038\/sj.mt.6300213_bib22","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood-2005-10-4240","article-title":"The molecular pathogenesis of Fanconi anemia: recent progress","volume":"107","author":"Taniguchi","year":"2006","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300213_bib23","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood.V94.6.1855","article-title":"Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment","volume":"94","author":"Ogilvy","year":"1999","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300213_bib24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.exphem.2004.01.005","article-title":"Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice","volume":"32","author":"Almarza","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1038\/sj.mt.6300213_bib25","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1128\/JVI.78.16.8421-8436.2004","article-title":"Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration","volume":"78","author":"Logan","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/sj.mt.6300213_bib26","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1073\/pnas.91.7.2567","article-title":"Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo","volume":"91","author":"Challita","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300213_bib27","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/carcin\/bgg118","article-title":"Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87","volume":"24","author":"Grassi","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1038\/sj.mt.6300213_bib28","article-title":"Gene Therapy of Chronic Granulomatous Disease","author":"Grez","year":"2006","journal-title":"XIV Annual Congress of the European Society of Gene Therapy"},{"key":"10.1038\/sj.mt.6300213_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood-2005-05-2032","article-title":"Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity","volume":"107","author":"Lagresle-Peyrou","year":"2006","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300213_bib30","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2002-03-0767","article-title":"High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation","volume":"101","author":"Schiedlmeier","year":"2003","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300213_bib31","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/4401123a","article-title":"Gene therapy: therapeutic gene causing lymphoma","volume":"440","author":"Woods","year":"2006","journal-title":"Nature"},{"key":"10.1038\/sj.mt.6300213_bib32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/104303403764539305","article-title":"Comparison of three retroviral vector systems for transduction of nonobese diabetic\/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells","volume":"14","author":"Leurs","year":"2003","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300213_bib33","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ymthe.2004.11.017","article-title":"Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector","volume":"11","author":"Vigna","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300213_bib34","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/00007890-199905270-00010","article-title":"Preserved long-term repopulation and differentiation properties of hematopoietic grafts subjected to ex vivo expansion with stem cell factor and interleukin 11","volume":"67","author":"Albella","year":"1999","journal-title":"Transplantation"},{"key":"10.1038\/sj.mt.6300213_bib35","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood.V100.6.2032","article-title":"In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice","volume":"100","author":"Rio","year":"2002","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300213_bib36","first-page":"981","article-title":"Relevance of myeloablative conditioning in the engraftment of limiting numbers of normal and genetically marked lympho-hematopoietic stem cells","volume":"18","author":"Varas","year":"1996","journal-title":"Bone Marrow Transpl"},{"key":"10.1038\/sj.mt.6300213_bib37","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood.V93.3.1097","article-title":"Delayed engraftment of nonobese diabetic\/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells","volume":"93","author":"Guenechea","year":"1999","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300213_bib38","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1182\/blood-2006-09-047043","article-title":"Epigenetic regulation of Wnt signaling pathway in acute lymphoblastic leukemia","volume":"109","author":"Roman-Gomez","year":"2007","journal-title":"Blood"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616324431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616324431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T12:36:07Z","timestamp":1587558967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616324431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1525001616324431"],"URL":"https:\/\/doi.org\/10.1038\/sj.mt.6300213","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}